M E8 (Estropipate 1.5 mg)
Pill with imprint M E8 is Orange, Round and has been identified as Estropipate 1.5 mg. It is supplied by Mylan Pharmaceuticals Inc..
Estropipate is used in the treatment of postmenopausal symptoms; atrophic vaginitis; oophorectomy; primary ovarian failure; atrophic urethritis (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M E8
Estropipate
- Imprint:
- M E8
- Strength:
- 1.5 mg
- Color:
- Orange
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Estrogens
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
croscarmellose sodium
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
Note: Inactive ingredients may vary.
More about estropipate
- Estropipate Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: estrogens
Consumer resources
Other brands: Ogen 2.5, Ogen 0.625, Ogen 1.25, Ortho-Est
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
